Application guide for omics approaches to cell signaling

Nature Chemical Biology

Volumn 11, Issue 6, 2015, Pages 387-397

  Yao, Zhong ^a   Petschnigg, Julia ^b   Ketteler, Robin ^b   Stagljar, Igor ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; IMATINIB; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; PROTEOME;

BIOMICS; CHEMICAL GENETICS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONFORMATIONAL TRANSITION; CRISPR CAS SYSTEM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; FUNCTIONAL GENOMICS; HUMAN; ISOBARIC TAG FOR RELATIVE AND ABSOLUTE QUANTITATION; ISOTOPE LABELING; LIGAND BINDING; LIQUID CHROMATOGRAPHY; MAMMAL MEMBRANE TWO HYBRID SYSTEM; MAMMAL PROTEIN PROTEIN INTERACTION TRAP; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN-FRAGMENT COMPLEMENTATION ASSAY; PROTEOMICS; PROXIMITY DEPENDENT BIOTIN IDENTIFICATION; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; REVIEW; SELECTED REACTION MONITORING; SEQUENTIAL WINDOW ACQUISITION OF ALL THEORETICAL SPECTRA; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; STABLE ISOTOPE LABELING BY AMINO ACIDS IN CELL CULTURE; TANDEM MASS SPECTROMETRY; TWO HYBRID SYSTEM; DRUG EFFECTS; GENETICS; MEDICAL RESEARCH; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN MICROARRAY;

BIOMEDICAL RESEARCH; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84929297907     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1809     Document Type: Review

References (100)

1. Olsen, J.V. & Mann, M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteomics 12, 3444-3452 (2013).
2. Serber, Z. & Ferrell, J.E. Jr. Tuning bulk electrostatics to regulate protein function. Cell 128, 441-444 (2007).
3. Choudhary, C., Weinert, B.T., Nishida, Y., Verdin, E. & Mann, M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15, 536-550 (2014).
4. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956 (2007).
5. Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730-738 (2007).
6. Pawson, T. & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027-1047 (2000).
7. Petschnigg, J., Snider, J. & Stagljar, I. Interactive proteomics research technologies: recent applications and advances. Curr. Opin. Biotechnol. 22, 50-58 (2011).
8. Teruel, M.N. & Meyer, T. Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell 103, 181-184 (2000).
9. Alon, U. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8, 450-461 (2007).
10. Berger, B., Peng, J. & Singh, M. Computational solutions for omics data. Nat. Rev. Genet. 14, 333-346 (2013).
11. Joyce, A.R. & Palsson, B.O. The model organism as a system: integrating 'omics' data sets. Nat. Rev. Mol. Cell Biol. 7, 198-210 (2006).
12. Kolch, W. & Pitt, A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat. Rev. Cancer 10, 618-629 (2010).
13. Kristensen, V.N. et al. Principles and methods of integrative genomic analyses in cancer. Nat. Rev. Cancer 14, 299-313 (2014).
14. Rigaut, G. et al. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17, 1030-1032 (1999).
15. Ong, S.E. & Mann, M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1, 252-262 (2005).
16. Lange, V., Picotti, P., Domon, B. & Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222 (2008).
17. Bisson, N. et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat. Biotechnol. 29, 653-658 (2011).
18. Zheng, Y. et al. Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166-171 (2013).
19. Gillet, L.C. et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, O111.016717 (2012).
20. Collins, B.C. et al. Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat. Methods 10, 1246-1253 (2013).
21. Lambert, J.P. et al. Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition. Nat. Methods 10, 1239-1245 (2013).
22. Bandura, D.R. et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal. Chem. 81, 6813-6822 (2009).
23. Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
24. Bodenmiller, B. et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30, 858-867 (2012).
25. Nomura, D.K., Dix, M.M. & Cravatt, B.F. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat. Rev. Cancer 10, 630-638 (2010).
26. Rix, U. & Superti-Furga, G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5, 616-624 (2009).
27. Bantscheff, M. et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265 (2011).
28. Huber, K.V. et al. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature 508, 222-227 (2014).
29. Daub, H. et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell 31, 438-448 (2008).
30. Duncan, J.S. et al. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 149, 307-321 (2012).
31. Savas, J.N., Stein, B.D., Wu, C.C. & Yates, J.R. III. Mass spectrometry accelerates membrane protein analysis. Trends Biochem. Sci. 36, 388-396 (2011).
32. Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989).
33. Stefan, E. et al. Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo. Proc. Natl. Acad. Sci. USA 104, 16916-16921 (2007).
34. Wehr, M.C. et al. Monitoring regulated protein-protein interactions using split TEV. Nat. Methods 3, 985-993 (2006).
35. Wehrman, T.S. et al. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proc. Natl. Acad. Sci. USA 103, 19063-19068 (2006).
36. Michnick, S.W., Remy, I., Campbell-Valois, F.X., Vallee-Belisle, A. & Pelletier, J.N. Detection of protein-protein interactions by protein fragment complementation strategies. Methods Enzymol. 328, 208-230 (2000).
37. Kerppola, T.K. Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation. Chem. Soc. Rev. 38, 2876-2886 (2009).
38. Tchekanda, E., Sivanesan, D. & Michnick, S.W. An infrared reporter to detect spatiotemporal dynamics of protein-protein interactions. Nat. Methods 11, 641-644 (2014).
39. Lemmens, I. et al. Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. Nucleic Acids Res. 31, e75 (2003).
40. Lemmens, I., Lievens, S., Eyckerman, S. & Tavernier, J. Reverse MAPPIT detects disruptors of protein-protein interactions in human cells. Nat. Protoc. 1, 92-97 (2006).
41. Lievens, S. et al. KISS, a mammalian in situ protein interaction sensor. Mol. Cell. Proteomics 13, 3332-3342 (2014).
42. Petschnigg, J. et al. The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat. Methods 11, 585-592 (2014).
43. Deribe, Y.L. et al. Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci. Signal. 2, ra84 (2009).
44. Stagljar, I., Korostensky, C., Johnsson, N. & te Heesen, S. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. USA 95, 5187-5192 (1998).
45. Ciruela, F. Fluorescence-based methods in the study of protein-protein interactions in living cells. Curr. Opin. Biotechnol. 19, 338-343 (2008).
46. Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (2006).
47. Gu, G.J. et al. Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation. N. Biotechnol. 30, 144-152 (2013).
48. Leuchowius, K.J. et al. Parallel visualization of multiple protein complexes in individual cells in tumor tissue. Mol. Cell. Proteomics 12, 1563-1571 (2013).
49. Smith, M.A. et al. Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays. Sci. Signal. 8, ra4 (2015).
50. Roux, K.J., Kim, D.I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801-810 (2012).
51. Couzens, A.L. et al. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci. Signal. 6, rs15 (2013).
52. Heintze, J., Luft, C. & Ketteler, R. A CRISPR CASe for high-throughput silencing. Front. Genet. 4, 193 (2013).
53. Ketteler, R. On programmed ribosomal frameshifting: the alternative proteomes. Front. Genet. 3, 242 (2012).
54. Seed, B. Developments in expression cloning. Curr. Opin. Biotechnol. 6, 567-573 (1995).
55. Luo, J. et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835-848 (2009).
56. Neumann, B. et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 464, 721-727 (2010).
57. Pelkmans, L. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78-86 (2005).
58. Mercer, J. et al. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Reports 2, 1036-1047 (2012).
59. Marine, S. et al. High-throughput transfection of differentiated primary neurons from rat forebrain. J. Biomol. Screen. 17, 692-696 (2012).
60. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298 (2006).
61. Hasson, S.A. et al. High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature 504, 291-295 (2013).
62. Birmingham, A. et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 3, 199-204 (2006).
63. Franceschini, A. et al. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc. Natl. Acad. Sci. USA 111, 4548-4553 (2014).
64. Jackson, A.L. et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179-1187 (2006).
65. Mohr, S.E., Smith, J.A., Shamu, C.E., Neumuller, R.A. & Perrimon, N. RNAi screening comes of age: improved techniques and complementary approaches. Nat. Rev. Mol. Cell Biol. 15, 591-600 (2014).
66. Bushman, F.D. et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 5, e1000437 (2009).
67. Snijder, B. et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol. Syst. Biol. 8, 579 (2012).
68. Reyon, D. et al. FLASH assembly of TALENs for high-throughput genome editing. Nat. Biotechnol. 30, 460-465 (2012).
69. Jinek, M. et al. RNA-programmed genome editing in human cells. Elife 2, e00471 (2013).
70. Kasap, C., Elemento, O. & Kapoor, T.M. DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets. Nat. Chem. Biol. 10, 626-628 (2014).
71. Smurnyy, Y. et al. DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells. Nat. Chem. Biol. 10, 623-625 (2014).
72. Gilbert, L.A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647-661 (2014).
73. Koike-Yusa, H., Li, Y., Tan, E.P., Velasco-Herrera Mdel, C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267-273 (2014).
74. Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87 (2014).
75. Wang, T., Wei, J.J., Sabatini, D.M. & Lander, E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80-84 (2014).
76. Wutz, A. Haploid animal cells. Development 141, 1423-1426 (2014).
77. Kaufman, C.K., White, R.M. & Zon, L. Chemical genetic screening in the zebrafish embryo. Nat. Protoc. 4, 1422-1432 (2009).
78. Specht, K.M. & Shokat, K.M. The emerging power of chemical genetics. Curr. Opin. Cell Biol. 14, 155-159 (2002).
79. Alaimo, P.J., Shogren-Knaak, M.A. & Shokat, K.M. Chemical genetic approaches for the elucidation of signaling pathways. Curr. Opin. Chem. Biol. 5, 360-367 (2001).
80. Muellner, M.K. et al. A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat. Chem. Biol. 7, 787-793 (2011).
81. Banko, M.R. et al. Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell 44, 878-892 (2011).
82. Kokel, D. et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 6, 231-237 (2010).
83. Gonsalves, F.C. et al. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc. Natl. Acad. Sci. USA 108, 5954-5963 (2011).
84. Weidle, U.H., Auer, J., Brinkmann, U., Georges, G. & Tiefenthaler, G. The emerging role of new protein scaffold-based agents for treatment of cancer. Cancer Genomics Proteomics 10, 155-168 (2013).
85. Koide, A., Wojcik, J., Gilbreth, R.N., Hoey, R.J. & Koide, S. Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold. J. Mol. Biol. 415, 393-405 (2012).
86. Grebien, F. et al. Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell 147, 306-319 (2011).
87. Deininger, M., Buchdunger, E. & Druker, B.J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640-2653 (2005).
88. Jabbour, E., Hochhaus, A., Cortes, J., La Rosee, P. & Kantarjian, H.M. Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history. Leukemia 24, 6-12 (2010).
89. Sha, F. et al. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains. Proc. Natl. Acad. Sci. USA 110, 14924-14929 (2013).
90. Campbell, S.J. & Jackson, R.M. Diversity in the SH2 domain family phosphotyrosyl peptide binding site. Protein Eng. 16, 217-227 (2003).
91. Wojcik, J. et al. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat. Struct. Mol. Biol. 17, 519-527 (2010).
92. Tiede, C. et al. Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications. Protein Eng. Des. Sel. 27, 145-155 (2014).
93. Taylor, I.W. et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol. 27, 199-204 (2009).
94. Braun, P. et al. An experimentally derived confidence score for binary protein-protein interactions. Nat. Methods 6, 91-97 (2009).
95. Hart, T., Brown, K.R., Sircoulomb, F., Rottapel, R. & Moffat, J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 10, 733 (2014).
96. Zuzuarregui, A. et al. M-Track: detecting short-lived protein-protein interactions in vivo. Nat. Methods 9, 594-596 (2012).
97. Sharma, K. et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Reports 8, 1583-1594 (2014).
98. Lemmon, M.A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 (2010).
99. Lefkowitz, R.J. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 25, 413-422 (2004).
100. Newton, K. & Dixit, V.M. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 4, a006049 (2012).